|
TOP3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28599999999579E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.141400E-03 |
| Normal-vs-Stage2 |
1.912990E-01 |
| Normal-vs-Stage3 |
9.459300E-03 |
| Normal-vs-Stage4 |
8.475800E-01 |
| Stage1-vs-Stage2 |
9.736800E-01 |
| Stage1-vs-Stage3 |
1.305620E-01 |
| Stage1-vs-Stage4 |
4.432000E-01 |
| Stage2-vs-Stage3 |
2.317000E-01 |
| Stage2-vs-Stage4 |
5.155400E-01 |
| Stage3-vs-Stage4 |
1.500230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.84500000000232E-05 |
| Normal-vs-AfricanAmerican |
1.566610E-01 |
| Normal-vs-Asian |
2.149000E-01 |
| Caucasian-vs-AfricanAmerican |
3.521900E-02 |
| Caucasian-vs-Asian |
4.986000E-01 |
| AfricanAmerican-vs-Asian |
1.100550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.819710E-04 |
| Normal-vs-Female |
1.684690E-03 |
| Male-vs-Female |
2.993600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.683400E-01 |
| Normal-vs-Extreme_Weight |
1.487560E-02 |
| Normal-vs-Obese |
1.918350E-03 |
| Normal-vs-Extreme_Obese |
2.923800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.762400E-01 |
| Normal_Weight-vs-Obese |
1.431760E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.855800E-01 |
| Extreme_Weight-vs-Obese |
2.573600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.910200E-01 |
| Obese-vs-Extreme_Obese |
7.666200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.480600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.56990000002677E-06 |
| Normal-vs-Age(61-80Yrs) |
1.770280E-02 |
| Normal-vs-Age(81-100Yrs) |
4.472000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.267500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.455500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.736300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.419710E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.017640E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.094400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67389999972123E-07 |
| Normal-VS-Type2 PRCC |
4.186200E-01 |
| Normal-VS-KIRP CIMP |
8.694300E-02 |
| Normal-VS-Unclassified PRCC |
1.234000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.188400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.089400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.640800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.679800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.185200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.787600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.642200E-01 |
| Normal-vs-N1 |
1.033630E-02 |
| Normal-vs-N2 |
6.299600E-02 |
| N0-vs-N1 |
6.316100E-02 |
| N0-vs-N2 |
2.866000E-01 |
| N1-vs-N2 |
8.586500E-02 |
|
|
